Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junjie Xi

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Annals of Translational Medicine|March 12, 2021
Analysis of the differences in lung cancer research trends between China and the United States based using project funding dataYuansheng Zheng, Yiwei Huang, Yunyi Bian, et al.
Translational Cancer Research|February 4, 2022
Development and validation of a nomogram for predicting the overall survival of patients with lung large cell neuroendocrine carcinomaJunjie Xi, Mengnan Zhao, Yuansheng Zheng, et al.
Heliyon|September 12, 2024
Dissection of the cell communication interactions in lung adenocarcinoma identified a prognostic model with immunotherapy efficacy assessment and a potential therapeutic candidate gene ITGB1Xing Jin, Zhengyang Hu, Jiacheng Yin, et al.
Cellular Oncology (Dordrecht, Netherlands)|October 12, 2022
FSCN1 induced PTPRF-dependent tumor microenvironment inflammatory reprogramming promotes lung adenocarcinoma progression via regulating macrophagic glycolysisYiwei Huang, Guangyao Shan, Yanjun Yi, et al.
Cancer Immunology, Immunotherapy : CII|November 27, 2021
Metformin inhibits human non-small cell lung cancer by regulating AMPK-CEBPB-PDL1 signaling pathwayTao Lu, Ming Li, Mengnan Zhao, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 21, 2021
HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancerYiwei Huang, Zhencong Chen, Tao Lu, et al.
Immunobiology|February 22, 2025
Preclinical models of immune checkpoint inhibitors-related interstitial pneumonia for anti-PD1 tumor immunotherapyTingyue Luo, Weisheng Chen, Danhui Huang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 10, 2026
Targeting UXS1-Dependent Glucuronate Detoxification Potentiates Metformin's Anti-Tumor Efficacy in Lung AdenocarcinomaQihai Sui, Zhencong Chen, Guangyao Shan, et al.
International Immunopharmacology|April 22, 2025
Development and validation of a CT-based radiomics machine learning model for differentiating immune-related interstitial pneumoniaTingyue Luo, Jingze Guo, Junjie Xi, et al.
Clinical and Translational Medicine|March 30, 2021
Landscape and dynamics of single tumor and immune cells in early and advanced-stage lung adenocarcinomaZhencong Chen, Yiwei Huang, Zhengyang Hu, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Annals of Translational Medicine|March 12, 2021
Analysis of the differences in lung cancer research trends between China and the United States based using project funding dataYuansheng Zheng, Yiwei Huang, Yunyi Bian, et al.
Translational Cancer Research|February 4, 2022
Development and validation of a nomogram for predicting the overall survival of patients with lung large cell neuroendocrine carcinomaJunjie Xi, Mengnan Zhao, Yuansheng Zheng, et al.
Heliyon|September 12, 2024
Dissection of the cell communication interactions in lung adenocarcinoma identified a prognostic model with immunotherapy efficacy assessment and a potential therapeutic candidate gene ITGB1Xing Jin, Zhengyang Hu, Jiacheng Yin, et al.
Cellular Oncology (Dordrecht, Netherlands)|October 12, 2022
FSCN1 induced PTPRF-dependent tumor microenvironment inflammatory reprogramming promotes lung adenocarcinoma progression via regulating macrophagic glycolysisYiwei Huang, Guangyao Shan, Yanjun Yi, et al.
Cancer Immunology, Immunotherapy : CII|November 27, 2021
Metformin inhibits human non-small cell lung cancer by regulating AMPK-CEBPB-PDL1 signaling pathwayTao Lu, Ming Li, Mengnan Zhao, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 21, 2021
HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancerYiwei Huang, Zhencong Chen, Tao Lu, et al.
Immunobiology|February 22, 2025
Preclinical models of immune checkpoint inhibitors-related interstitial pneumonia for anti-PD1 tumor immunotherapyTingyue Luo, Weisheng Chen, Danhui Huang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 10, 2026
Targeting UXS1-Dependent Glucuronate Detoxification Potentiates Metformin's Anti-Tumor Efficacy in Lung AdenocarcinomaQihai Sui, Zhencong Chen, Guangyao Shan, et al.
International Immunopharmacology|April 22, 2025
Development and validation of a CT-based radiomics machine learning model for differentiating immune-related interstitial pneumoniaTingyue Luo, Jingze Guo, Junjie Xi, et al.
Clinical and Translational Medicine|March 30, 2021
Landscape and dynamics of single tumor and immune cells in early and advanced-stage lung adenocarcinomaZhencong Chen, Yiwei Huang, Zhengyang Hu, et al.
Pageof 6